Capricor Therapeutics EVP, General Counsel Karen Krasney sells 900 shares for $27,000

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc.

CAPR

0.00
  • Capricor Therapeutics EVP and General Counsel Karen Krasney exercised stock options for 900 shares at USD 3.18 on June 22-24.
  • Krasney sold 900 shares at USD 30 on the same dates.
  • She ended with 30,547 Capricor common shares directly owned.
  • Her stock options holdings fell to 55,361 following the exercises.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001593086-26-000010), on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.